The PSC Category AJ53 covers Research and Development (R&D) focused on advanced development within the Life Sciences domain. This category encompasses sophisticated scientific research and technological exploration in biological and medical fields, targeting high-level scientific investigations and technological innovations. The work typically involves complex research projects that bridge fundamental scientific discoveries with potential practical applications in biotechnology, medical research, and advanced life science technologies. No specific contract award details were provided with the initial data, so a comprehensive overview of recent awards cannot be generated. To obtain accurate award information, additional research or access to federal procurement databases would be necessary to document recent contract allocations, funding levels, recipient organizations, and performance characteristics for this specific PSC category. No specific contract opportunities were included with the provided data. To develop a meaningful summary of current opportunities, supplemental information from sources like beta.SAM.gov or agency-specific procurement platforms would be required to outline potential solicitations, requesting agencies, performance requirements, and technical scope for R&D projects in the Life Sciences advanced development sector.
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Last Date To Order (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
MD316316 |
--
| Affymetrix, Inc. | $0 | 8/15/03 | 12/15/03 | 8/15/03 |
W81XWH16D0009 | Inbios International Inc. | $48.0m | 11/16/15 | 11/30/20 | 11/12/19 | |
W81XWH15D0042 | Engility Services, LLC | $900.0m | 7/31/15 | 8/2/23 | 6/23/23 | |
W81XWH15D0037 | Dynport Vaccine Company LLC | $900.0m | 7/31/15 | 8/2/23 | 7/19/23 | |
N6600108D0023 | University Of California San Diego | $1.5m | 3/20/08 | 3/6/13 | 6/29/11 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Definitive Contract N6600108C2014 | Genome Institute Of Singapore | $1.4m | 5/5/08 | 8/4/09 | 5/12/09 | |
Other Transaction Agreement W911QY1890010 | Ovc-Engineered Solutions LLC | $584.9k | 8/31/18 | 7/31/21 | 9/10/20 | |
Delivery Order W81XWH15D0037-0002 | Dynport Vaccine Company LLC | $24.2m | 3/22/17 | 7/31/22 | 12/21/23 | |
Definitive Contract W81XWH19C0054 | The Washington University | $9.5m | 1/11/19 | 10/10/23 | 8/9/23 | |
Other Transaction Agreement W911QY1890008 | Trelleborg Sealing Solutions Albany, Inc. | $398.8k | 8/23/18 | 1/31/20 | 11/27/19 |
Name | Description | Solicitation Number | Federal Agency | Type | Posted Date (Click to sort descending) |
|---|---|---|---|---|---|
BioFire Defense COVID-19 Test 510(k) with Sample Expansion Option | JA-20-04-0310 | Department of the Army Medical Command | Special Notice 1/1 | 6/23/20, 1:51 PM | |
Sample Type Expansion Studies for the BioFire Defense COVID-19 Test under Emergency Use Authorization | W81XWH20R0104 | Department of the Army Medical Command | Pre-Solicitation 1/3 | 8/3/20, 2:38 PM | |
Justification and Approval: Sample Type Expansion Studies for the BioFire Defense COVID-19 Test under Emergency Use Authorization | JA-20-08-00193 | Department of the Army Medical Command | Limited / Sole Source Justification 3/3 | 10/28/20, 3:18 PM | |
Notice of Intent: Sample Type Expansion Studies for the BioFire Defense COVID-19 Test under Emergency Use Authorization | W81XWH20R0104 | Department of the Army Medical Command | Special Notice 2/3 | 8/17/20, 11:32 AM |
A Portfolio Platform of GovExec © 2025